Univar Inc (NYSE:UNVR) Director William S. Stavropoulos bought 5,118 shares of the business’s stock in a transaction that occurred on Tuesday, August 13th. The shares were acquired at an average cost of $19.55 per share, with a total value of $100,056.90. Following the completion of the purchase, the director now owns 21,375 shares of the company’s stock, valued at $417,881.25. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Shares of NYSE:UNVR traded up $0.11 during mid-day trading on Tuesday, hitting $19.36. The stock had a trading volume of 2,507,334 shares, compared to its average volume of 1,727,247. The company has a current ratio of 1.75, a quick ratio of 1.17 and a debt-to-equity ratio of 1.76. The stock has a market capitalization of $3.41 billion, a P/E ratio of 11.95, a PEG ratio of 1.62 and a beta of 1.54. Univar Inc has a 12-month low of $16.33 and a 12-month high of $31.23. The firm’s 50 day simple moving average is $21.25.

Univar (NYSE:UNVR) last issued its quarterly earnings results on Monday, August 5th. The basic materials company reported $0.42 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.44 by ($0.02). The firm had revenue of $2.58 billion during the quarter, compared to analysts’ expectations of $2.83 billion. Univar had a net margin of 0.04% and a return on equity of 15.03%. The firm’s revenue was up 8.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.47 EPS. As a group, equities research analysts anticipate that Univar Inc will post 1.45 EPS for the current fiscal year.

Several analysts recently commented on UNVR shares. Berenberg Bank lowered shares of Univar from a “buy” rating to a “hold” rating and cut their target price for the company from $27.00 to $25.00 in a research note on Wednesday, April 17th. Goldman Sachs Group started coverage on shares of Univar in a research note on Thursday, April 18th. They set a “neutral” rating for the company. Finally, Zacks Investment Research raised shares of Univar from a “hold” rating to a “strong-buy” rating and set a $21.00 target price for the company in a research note on Monday, June 3rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $26.80.

Large investors have recently modified their holdings of the stock. Nisa Investment Advisors LLC purchased a new stake in shares of Univar in the 1st quarter valued at approximately $27,000. Meeder Asset Management Inc. lifted its position in shares of Univar by 291.7% in the 1st quarter. Meeder Asset Management Inc. now owns 1,849 shares of the basic materials company’s stock valued at $41,000 after acquiring an additional 1,377 shares in the last quarter. Machina Capital S.A.S. purchased a new stake in shares of Univar in the 2nd quarter valued at approximately $46,000. Marshall Wace North America L.P. purchased a new stake in shares of Univar in the 1st quarter valued at approximately $49,000. Finally, FNY Investment Advisers LLC purchased a new stake in shares of Univar in the 2nd quarter valued at approximately $55,000. Institutional investors and hedge funds own 94.07% of the company’s stock.

Univar Company Profile

Univar Inc distributes commodity and specialty chemical products, and related services worldwide. It offers herbicides, fungicides, insecticides, seeds, micro and macro nutrients, horticultural products, and fertilizers; storage, packaging, and logistics services for crop protection companies; and pest control products and equipment.

Featured Article: What is a conference call?

Insider Buying and Selling by Quarter for Univar (NYSE:UNVR)

Receive News & Ratings for Univar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Univar and related companies with MarketBeat.com's FREE daily email newsletter.